- CA$464.24m
- CA$320.69m
- $182.38m
- 69
- 30
- 79
- 62
Annual income statement for D2L, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 109 | 126 | 152 | 168 | 182 |
| Cost of Revenue | |||||
| Gross Profit | 69.3 | 77.1 | 87.9 | 108 | 122 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 115 | 125 | 227 | 189 | 189 |
| Operating Profit | -5.56 | 1.8 | -74.7 | -20.4 | -7.11 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.41 | -41.3 | -97.8 | -17.9 | -3.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.72 | -41.5 | -97.7 | -18.4 | -3.54 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.72 | -41.5 | -97.7 | -18.4 | -3.54 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.72 | -41.5 | -97.7 | -18.4 | -3.54 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.108 | -0.781 | -1.81 | -0.279 | -0.032 |
| Dividends per Share |